Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer
2024 · British Journal of Cancer · 42 citations
https://doi.org/10.1038/s41416-024-02766-9
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
8
Papers
47
Citations
2
h-index
1
i10-index
A. Gonçalves is an academic researcher from Institut Paoli-Calmettes. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Cervical Cancer and HPV Research & Breast Cancer Treatment Studies. The author has an h-index of 2, co-authored 7 publications.
ORCID: 0000-0001-9910-1626https://doi.org/10.1038/s41416-024-02766-9
https://doi.org/10.1016/j.neuchi.2016.01.007
Click to start Chat